851 doses of brand name xofigo (radium RA 223 dichloride) for loma linda nuclear medicine. Manufactured by bayer

Ended Awarded Last action

Contract number
36C26223F0003
Awardee
Awarding agency
Obligated
$55,476

Award facts

Contract value 100% obligated
$55,476.47 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Contracting staff
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
Dublin, OH 43017, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Supplemental Agreement for work within scope P00001 -$34,347
Original award $89,823

About this award

The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 22 awarded a $55,476.47 delivery order to Bayer Healthcare Pharmaceuticals Inc. for 851 doses of the brand name oncology drug Xofigo, also known as radium Ra 223 dichloride, to be provided to Loma Linda Nuclear Medicine by September 30, 2023. The delivery order was issued against Bayer Healthcare Pharmaceuticals Inc.'s Pharmaceuticals and Drugs Federal Supply Schedule contract, referred to as FSS-61-IB, for firm fixed price pharmaceuticals and drugs. Bayer AG is the parent company of Bayer Healthcare Pharmaceuticals Inc., which will fulfill the order from its Dublin, Ohio location. The delivery order will provide critically needed cancer treatment to veterans served by VISN 22 as it pursues its mission of ensuring accessible, high-quality healthcare for those who have served in the armed forces.

Quick answers

Who was awarded contract 36C26223F0003?

36C26223F0003 was awarded to Bayer Healthcare Pharmaceuticals Inc. by Veterans Integrated Service Network 22 (Veterans Health Administration) on October 1, 2022.

How much is contract 36C26223F0003 worth?

The government has obligated $55,476 on 36C26223F0003.

Is contract 36C26223F0003 an order under another contract?

Yes. 36C26223F0003 is a delivery order under 36F79720D0237, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).

Was contract 36C26223F0003 competed?

The extent of competition for 36C26223F0003 was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award